Table 7.
Risk factor | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
| ||||||
HR | 95% CI | p | HR | 95% CI | p | |
Sex (female) | 3.095 | 1.194–8.019 | 0.0200 | 1.213 | 0.377–3.905 | 0.7464 |
Age | 1.013 | 0.985–1.041 | 0.3753 | |||
Cancer | 0.260 | 0.085–0.794 | 0.0181 | 0.500 | 0.132–1.894 | 0.3077 |
Diabetes mellitus | 1.469 | 0.497–4.372 | 0.4872 | |||
Cerebral disease | 1.552 | 0.207–11.639 | 0.6691 | |||
Neurological disease | 0.750 | 0.065–8.646 | 0.8176 | |||
Leukocyte | 1.000 | 1.000–1.000 | 0.0348 | 1.000 | 1.000–1.000 | 0.9962 |
Platelet | 0.915 | 0.863–0.970 | 0.0029 | 0.957 | 0.899–1.018 | 0.1604 |
C-reactive protein | 1.117 | 1.060–1.177 | <0.0001 | 1.098 | 1.030–1.170 | 0.0041 |
Urological obstruction | 0.484 | 0.180–1.301 | 0.1502 | |||
E. coli | 2.046 | 0.775–5.402 | 0.1482 | |||
E. coli (ESBL) | 2.821 | 0.622–12.785 | 0.1787 | |||
E. cloacae | 1.552 | 0.207–11.639 | 0.6691 | |||
E. faecalis | 0.489 | 0.049–4.928 | 0.5438 | |||
K. pneumoniae | 0.228 | 0.026–1.193 | 0.1812 | |||
P. aeruginosa | 0.280 | 0.031–2.521 | 0.2562 | |||
S. aureus | 0.489 | 0.049–4.928 | 0.5438 | |||
P. mirabillis | 1.553 | 0.092–25.468 | 0.7656 | |||
Ceftazidime resistance | 2.067 | 0.509–8.402 | 0.3100 | |||
Imipenem resistance | 0.394 | 0.076–2.037 | 0.2665 | |||
Levofloxacin resistance | 0.851 | 0.293–2.473 | 0.7665 |
CI: confidence interval; ESBL: extended-spectrum beta lactamase; HR: hazard ratio.